secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2023-02-23T23:59:59+00:00
Accession:  0001493152-23-005863
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals raises $15M via registered direct offering of Series F convertible preferred and warrants
--------------------------------------------------------------------------------

- 15,000 shares of Series F Convertible Preferred Stock, $1,000 stated value per share.
- Warrants to purchase up to 6,651,885 shares of common stock.
- Offering to accredited investors under Securities Purchase Agreement dated Feb 21, 2023.
- Legal opinions from DLA Piper and Haynes and Boone filed as exhibits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223005863/0001493152-23-005863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223005863/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer